CClinicalTrials.gg
CompletedNCT04688879Updated Dec 30, 2020

Thrombolysis With Intra-arterial Urokinase

An observational study in Arterial Occlusion Mesenteric Artery Superior, sponsored by Chang Gung Memorial Hospital. Completed at 1 site in Taiwan. Per ClinicalTrials.gov, last updated 2020-12-30.

Sponsored by Chang Gung Memorial Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
13
Sex
All
01

Study summary

Patients with acute superior mesenteric artery (SMA) occlusion were included in this study. The clinical presentation and effect of the recanalization of the SMA was analyzed on follow-up angiography.

Read the detailed description

Thirteen patients with acute SMA occlusion who underwent intra-arterial urokinase thrombolysis between 2008 and 2020 were retrospectively evaluated.

Clinically, the abdominal pain and the effect of the SMA on angiography will be compared in response and non-response groups.

02

Conditions studied

  • Arterial Occlusion Mesenteric Artery Superior

Keywords

  • intra-arterial urokinase
03

In context

Arterial Occlusive Diseases

296 studies on the registry are indexed under Arterial Occlusive Diseases; 46 are open to participants now.

This study's enrollment of 13 is below the median of 183 across 75 observational studies indexed under Arterial Occlusive Diseases.

Browse Arterial Occlusive Diseases studies →

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

13

Inclusion criteria

  • Clinical diagnosis of SMA occlusion

Exclusion criteria

Exclusion Criteria:

  • shock in the triage screening
  • peritonitis
    1. intramural gas, mesenteric or portal venous gas on contrast-enhanced abdominal CT
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
13 participants (actual)
Patient registry
No

Groups and cohorts

  • According to the degree of occlusion, 13 patients were divided into complete and incomplete groups.

    Seven patients were complete occlusion and 6 patients were incomplete occlusion and all underwent thrombolysis with intra-arterial urokinase and the outcome was analysed..

    Procedure: intra-arterial urokinase thrombolysis

Interventions

  • Procedureintra-arterial urokinase thrombolysis

    Under local anaesthesia, the right femoral artery was punctured in accordance with the Seldinger technique, and a 6-Fr sheath, 10 cm in length, was implanted. Selective catheterization of the SMA was performed with 4-Fr catheter. The SMA angiography was performed to identify the filling defect. Thrombolysis was performed using a 5-Fr multiple-sideport infusion catheter (100cm with sideport of 7cm, 14 ports or 100cm with sideport of 15cm, 30 ports, Cook, Bloomington, IN, U.S.A). The tip of the microcatheter was embedded in the thromboembolism, which was fragmented at the time of thrombolysis. Thrombolysis was performed locally in the SMA with a bolus of urokinase

06

What researchers measure

Primary outcomes

  1. Thrombolysis with intra-arterial urokinase for acute superior mesenteric artery occlusion: Outcome analysis

    Degree of patency and appearance of the SMA will be analyzed in the follow-up angiography.

    Time frame: Daily series follow-up angiography in the next 72 hours after thrombolysis with intra-arterial urokinase.

07

Study locations

1 site
  • Chang Gung memorial Hospital
    TaoYuan City, 886, Taiwan
08

References and documents

Publications

  • Bala M, Kashuk J, Moore EE, Kluger Y, Biffl W, Gomes CA, Ben-Ishay O, Rubinstein C, Balogh ZJ, Civil I, Coccolini F, Leppaniemi A, Peitzman A, Ansaloni L, Sugrue M, Sartelli M, Di Saverio S, Fraga GP, Catena F. Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery. World J Emerg Surg. 2017 Aug 7;12:38. doi: 10.1186/s13017-017-0150-5. eCollection 2017. PubMed 28794797 ↗
  • Bjornsson S, Bjorck M, Block T, Resch T, Acosta S. Thrombolysis for acute occlusion of the superior mesenteric artery. J Vasc Surg. 2011 Dec;54(6):1734-42. doi: 10.1016/j.jvs.2011.07.054. Epub 2011 Sep 1. PubMed 21889287 ↗
  • Tilsed JV, Casamassima A, Kurihara H, Mariani D, Martinez I, Pereira J, Ponchietti L, Shamiyeh A, Al-Ayoubi F, Barco LA, Ceolin M, D'Almeida AJ, Hilario S, Olavarria AL, Ozmen MM, Pinheiro LF, Poeze M, Triantos G, Fuentes FT, Sierra SU, Soreide K, Yanar H. ESTES guidelines: acute mesenteric ischaemia. Eur J Trauma Emerg Surg. 2016 Apr;42(2):253-70. doi: 10.1007/s00068-016-0634-0. PubMed 26820988 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 30, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04688879
Lead sponsor
Chang Gung Memorial Hospital
Responsible party
Being-Chuan Lin (Attending doctor of the Trauma & Emergency Surgery, Chang Gung Memorial Hospital) — Principal investigator
First posted
Dec 30, 2020
Start date
Mar 1, 2020
Primary completion
Sep 1, 2020
Completion
Sep 1, 2020
Last update
Dec 30, 2020

Study contacts

Being-Chuan Lin
study director · Chang Gung Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion